Literature DB >> 22811821

Insulin-resistant conditions: A favorable milieu for aggressive drug-resistant malignancies.

Matteo Landriscina1, Franca Esposito.   

Abstract

Entities:  

Year:  2011        PMID： 22811821      PMCID： PMC3397586          DOI： 10.3978/j.issn.2078-6891.2011.004

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  7 in total

1.  Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.

Authors:  Matteo Landriscina; Gabriella Laudiero; Francesca Maddalena; Maria Rosaria Amoroso; Annamaria Piscazzi; Flora Cozzolino; Maria Monti; Corrado Garbi; Alberto Fersini; Piero Pucci; Franca Esposito
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Metformin and reduced risk of cancer in diabetic patients.

Authors:  Josie M M Evans; Louise A Donnelly; Alistair M Emslie-Smith; Dario R Alessi; Andrew D Morris
Journal:  BMJ       Date:  2005-04-22

3.  Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.

Authors:  Jiezhong Chen; Xu-Feng Huang; Liang Qiao; Andrew Katsifis
Journal:  J Gastrointest Oncol       Date:  2011-03

Review 4.  Metformin: taking away the candy for cancer?

Authors:  Mathilde Jalving; Jourik A Gietema; Joop D Lefrandt; Steven de Jong; Anna K L Reyners; Rijk O B Gans; Elisabeth G E de Vries
Journal:  Eur J Cancer       Date:  2010-07-23       Impact factor: 9.162

Review 5.  Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.

Authors:  Piotr J Wysocki; Bogna Wierusz-Wysocka
Journal:  Expert Rev Mol Diagn       Date:  2010-05       Impact factor: 5.225

Review 6.  PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.

Authors:  Marco Falasca
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 7.  Diabetes and cancer.

Authors:  Paolo Vigneri; Francesco Frasca; Laura Sciacca; Giuseppe Pandini; Riccardo Vigneri
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678
  7 in total
  4 in total

Review 1.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

2.  A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival.

Authors:  R Ramjeesingh; C Orr; C S Bricks; W M Hopman; N Hammad
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

3.  Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients.

Authors:  Francesca Bella; Pamela Minicozzi; Adriano Giacomin; Emanuele Crocetti; Massimo Federico; Maurizio Ponz de Leon; Mario Fusco; Rosario Tumino; Lucia Mangone; Orietta Giuliani; Mario Budroni; Milena Sant
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-30       Impact factor: 4.553

4.  Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis.

Authors:  Jingtao Li; Jixi Liu; Chun Gao; Fang Liu; Hongchuan Zhao
Journal:  Oncotarget       Date:  2017-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.